Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

GW PHARMACEUTICALS PLC (GWPH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Sep-30-18Sep-30-16
   10-K10-K8-K10-KSource
Revenues       
Total revenues  527.2311.315.412.712.7
            Total revenues growth  69.3%1921.8%   
Operating expenses       
Cost of product sales  37.527.26.66.03.8
Research and development  205.4142.7 153.7104.4
Selling, general and administrative  336.0259.9165.7141.833.2
    Total operating expenses  579.0429.8325.6301.5141.4
    Loss from operations  -51.8-118.4-303.6-288.8-128.7
            Operating margin  -9.8%-38.0%-1971.6%-2267.4%-1010.6%
Interest income  1.88.55.53.60.6
Interest expense  -1.1-1.1-1.2-1.2-0.2
Foreign exchange loss  -4.0-2.3-6.1-5.035.9
    Loss before income taxes  -55.0-9.2 -291.4-92.4
Income tax (benefit) expense  3.1-0.2-0.23.8-0.7
    Net loss  -58.1-9.0-305.3-295.2-91.7
   
Net loss per share:       
Basic  ($0.15)($0.02)($0.88)($0.88)($0.34)
Diluted  ($0.15)($0.02)($0.88)($0.88)($0.34)
   
Weighted average shares outstanding:       
Basic  375.6371.6347.1333.9272.2
Diluted  375.6371.6347.1333.9 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy